By vgreene, 28 January, 2021 If daily tx given only during specific seasons periods of previously documented risk ensure action plan F U 2 6wk after tx d c d
By vgreene, 28 January, 2021 If clear benefit sustained 3 mo consider step down in ICS dose pts this age have high spontaneous remission rates
By vgreene, 28 January, 2021 If no clear benefit observed in 4 6wk consider d c ing or adjusting tx or alternative dx
By vgreene, 28 January, 2021 F U q2 6wk while gaining control q1 6mo to monitor control q3mo if step down tx anticipated
By vgreene, 28 January, 2021 Educate sx meds inhaler technique environment control based on allergen exposure 7 comorbidity8 mgmt
